AdvanSource Biomaterials Corp
ASB
ASB was delisted on the 23rd of November, 2010.
0 hedge funds and large institutions have $0 invested in AdvanSource Biomaterials Corp in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $1K → $0 (-$1K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JEW
Jamison Eaton & Wood
Bedminster,
New Jersey
|
-$1K |
ASB Hedge Fund Activity: Q4 2013 in Review
0 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in AdvanSource Biomaterials Corp (ASB) for Q4 2013, worth a combined $0 — down 100% from $1K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ASB and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Jamison Eaton & Wood, exiting entirely with an estimated $1K sold.
- 0 institutional investors held AdvanSource Biomaterials Corp (ASB) as of Q4 2013, down from 1 in Q3 2013.
- Funds reported $0 of AdvanSource Biomaterials Corp stock for Q4 2013, down 100% quarter-over-quarter.
- 0 funds opened new AdvanSource Biomaterials Corp positions in Q4 2013 and 1 closed out, a net change of -1 holder.
- The largest AdvanSource Biomaterials Corp seller in Q4 2013 was Jamison Eaton & Wood, an estimated $1K sold.
Based on aggregated 13F filings for Q4 2013.